SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-009006
Filing Date
2015-10-30
Accepted
2015-10-30 16:41:36
Documents
5
Period of Report
2015-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ctic-8k_20151027.htm 8-K 43928
2 EX-1.1 ctic-ex11_6.htm EX-1.1 312070
3 EX-3.1 ctic-ex31_36.htm EX-3.1 124722
4 EX-3.2 ctic-ex32_35.htm EX-3.2 22624
5 EX-5.1 ctic-ex51_103.htm EX-5.1 17230
  Complete submission text file 0001564590-15-009006.txt   521959
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 151188036
SIC: 2834 Pharmaceutical Preparations